BfArM - Federal Institute for Drugs and Medical Devices

Navigation and service

EMA recommends new safety measures for Zydelig®: close monitoring and use of antibiotics to prevent pneumonia

Active substance: Idelalisib

EMA recommends new safety measures for Zydelig®: close monitoring and use of antibiotics to prevent pneumonia.

To the risk assessment procedure (available in German only)

For details on the procedure please click on the following link to the homepage of the European Medicines Agency (EMA):

EMA recommends new safety measures for Zydelig